Skip to main content

OP/Bone

RheumNow Podcast – Sweet Lies or Hard Truths? (2.26.2021)

Feb 26, 2021

Dr. Jack Cush reviews and discusses the news and Journal reports from the past week on RheumNow.com.

Read Article

Diagnosis & Treatment of Osteoarthritis Reviewed

Feb 22, 2021

Katz, Arant and Loeser have published a comprehensive open-read overview of osteoarthritis (OA) of the hip and knee in JAMA; underscoring the impact, advances, disappointments and guidelines put forth. 



OA affects an estimated more than 240 million people worldwide, and more

Read Article
RWCS Highlights - Day 2 by Dr. Rachel Tate ( @uptotate) -What’s new in Spondyloarthritis -Osteoporosis and Beyond -Immunologic basis and clinical characteristics https://t.co/q4lI2BYhfz https://t.co/Q79CHaQrHf
Dr. John Cush @RheumNow( View Tweet )
Feb 15, 2021

NSAIDs in Osteoarthritis: Study Suggests Need for New Look

Feb 08, 2021

Knee osteoarthritis (OA) patients using nonsteroidal anti-inflammatory drugs (NSAIDs) showed greater loss of medial minimum joint space width than did others taking other drugs, registry data indicated.



Compared with current non-users of NSAIDs, those who were treated with these

Read Article

Abrupt Cessation of Long-Term Opioid Prescribing Common

MedPage Today
Feb 05, 2021

Medicare beneficiaries were increasingly likely to have long-term opioid therapy stopped in recent years and medication changes often were abrupt, not tapered, an observational study showed.



Long-term opioid discontinuations among Medicare Part D beneficiaries increased by 49% from

Read Article

RheumNow Podcast – Tofacitinib Safety Concerns (2.5.2021)

Feb 05, 2021

Dr. Jack Cush reviews and discusses the news and journal reports from the past week on RheumNow.com.

Read Article
French study of 782 men (50-85 years) with DISH found DISH was associated with increased vertebral fractures (OR 2.89; 95% CI, 1.15-7.28; P <.05), but Nonvertebral fractures were not associated with DISH (HR 0.72; 0.33-1.56). https://t.co/YoQ8r62pns

Dr. John Cush @RheumNow( View Tweet )

Feb 01, 2021
Multiple intraarticular steroid injxs NO better than placebo. Analysis of 6 RCTs show no diff in pain than PBO (−0.47, 95% CI −0.62, 0.31). 14 RCTs + 2 Observ. studies show IA steroids may cause mor cartilage loss or risk of joint replacement (HR 2.54) https://t.co/jCLq4jWn4Y

Dr. John Cush @RheumNow( View Tweet )

Feb 01, 2021
News: #COVID19 risk may be reduced with #biologics and #JAKinhibitors, but increased with #glucocorticoids, Italian researchers report in @ArthritisRes https://t.co/zIef2aNCns

Medicine Matters rheumatology @Rheum_Matters( View Tweet )

Jan 29, 2021

RheumNow Podcast – Rheumatology Burnout (1.29.2021)

Jan 28, 2021

Dr. Jack Cush reviews this past week's journal articles and news features on RheumNow.com. Colchicine, vaccine rollout, risk of RA in endometriosis patients, tREACH trial, lupus nephritis news, rheumatology burnout and more.

Read Article

RheumNow Podcast – Don’t Hold the Benlysta, Take the Vaccine (1.22.2021)

Jan 22, 2021

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com, with more than a dozen items to discuss on this week's podcast.

Read Article
Denosumab inhibiting osteolysis? 22 pts undergoing revision THR surgery for osteolysis, 10 Rx w/ denosumab had 83% fewer osteoclasts @ osteolysis membrane–bone interface. Proof concept: DEN may have osteoclast effects at implant interface https://t.co/dJ06rk0SR3

Dr. John Cush @RheumNow( View Tweet )

Jan 21, 2021
Osteoporosis in Men - is often unrecognized till they fracture. Risk factors for OP in men: - Meds: steroids; PPI immunosuppressives - Chronic renal disease - Smoking, ^^alcohol - Sedentary lifestyle - Elderly - Family history: Osteoporosis https://t.co/V4P5wey070

Dr. John Cush @RheumNow( View Tweet )

Jan 20, 2021

Best of 2020: The COVID-19 Global Rheumatology Registry

Dec 24, 2020

What started out as online tweets and sharing newsfeed and case reports, has progressed to the formation of the COVID-19 Global Rheumatology Alliance, whose mission is to create an international rheumatology registry of patients affected by the disease in order to better understand the disease

Read Article

Best of 2020: A Rheumatologist’s Tips: Telemedicine in 6 Easy Steps

Dec 23, 2020

Ready for telemedicine/telerheumatology?

Once you and your patient agree on a virtual visit, the following suggestions may help facilitate the interaction. If you have the ability and the capacity, record the visit.

Read Article

Best of 2020: Rheumatic Disease Drugs and COVID-19

Dec 22, 2020

We are in the early stages of trying to limit the morbid and mortal consequences of the corona virus pandemic of 2020. Not surprisingly, the recommendations designed to limit exposure and damage continually highlight the fact that the elderly and immunosuppressed may be amongst the most

Read Article
New podcast! Dr Jack Cush takes questions from RheumNow listeners PIANO Study - Safety of Biologics in Pregnancy Premature osteoporosis and high tryptase Mega-methotrexate doses SLE criteria and SLEDAI substitutions https://t.co/45n3KjJHqs

Dr. John Cush @RheumNow( View Tweet )

Dec 07, 2020

RheumNow Podcast – Back Talk Listener Questions (12.04.20)

Dec 04, 2020

Dr Jack Cush takes questions from RheumNow listeners



  1. PIANO Study - Safety of Biologics in Pregnancy

  2. Premature osteoporosis and high tryptase

  3. Mega-methotrexate doses

  4. SLE
Read Article
Warfarin and Risk of Hip and Knee Replacements with Dr. Mrinalini Dey ( @DrMiniDey) #ACR20. https://t.co/znTxIx1QQZ https://t.co/elQlChwr0N
Dr. John Cush @RheumNow( View Tweet )
Nov 25, 2020
Dr. Kathryn Dao ( @KDAO2011) reviews abstract #0533 presented at #ACR20 on male osteoporosis. https://t.co/Z0NLcJzslV https://t.co/SSoIA7Eetg
Dr. John Cush @RheumNow( View Tweet )
Nov 24, 2020
We are underdiagnosing this! In pts with persistently low ALP, think hypophoshatasia (HPP); these pts have recurrent poor healing fractures, may have CPPD, and have been refractory to standard OP Rx. Dr. A Abelson #ACRReview @rheumnow #ACR20 https://t.co/dVptFkYXR2
Nov 10, 2020
Dr. A Abelson #ACRReview @rheumnow #ACR20 Romosozumab (sclerostin Ab) for OP: 👉can be used after previous treatmt with PTH analogs 👉can be used in pts with prior radiation exposure 👉not yet approved for men. Some slides on what to choose for OP and when to choose it https://t.co/nAbOmEjx3p
Nov 10, 2020
from #ACR20 Dr. Abbey Abelson. There was reduction in hip fractures in the US until there was drop in reimbursement for DEXA/Bone Density. @ACRheum has been advocating on Capitol Hill to restore reimbursement. Bad policy harms, but good policy can save lives. #ACRambassador https://t.co/ARo762Vozp
Suleman Bhana, MD @DrBhana( View Tweet )
Nov 10, 2020
ARCH study -- n~4100 Romo vs Alendronate x 12 mo Alendronate 12-24 mo RRR 38% https://t.co/d0G7x4TqUT
Vaneet K Sandhu, MD @vksandhumd( View Tweet )
Nov 10, 2020
How do we square up bone loss and new bone formation in AS? Are these coupled? Study from the ASSERT trial showed no relationship between baseline BMD and new syndesmophyte formation in the same vertebra @RheumNow #ACR20 Abstr#1896

Dr. Antoni Chan @synovialjoints( View Tweet )

Nov 09, 2020
×